These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11678953)

  • 41. Botulinum toxin therapy in the ovalbumin-sensitized rat.
    Wen WD; Yuan F; Wang JL; Hou YP
    Neuroimmunomodulation; 2007; 14(2):78-83. PubMed ID: 17713354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the vasoconstrictive and anesthetic effects of intranasally applied cocaine vs. xylometazoline/lidocaine solution.
    Campbell JP; Campbell CD; Warren DW; Prazma TU; Pillsbury HC
    Otolaryngol Head Neck Surg; 1992 Nov; 107(5):697-700. PubMed ID: 1279502
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term efficacy of microdebrider-assisted inferior turbinoplasty with lateralization for hypertrophic inferior turbinates in patients with perennial allergic rhinitis.
    Chen YL; Tan CT; Huang HM
    Laryngoscope; 2008 Jul; 118(7):1270-4. PubMed ID: 18401269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An Analysis of Neuropeptides at Nasal Contact Points of Patients With Secondary Headache.
    Demir D; Cengiz N; Güven M; Bulduk O
    J Craniofac Surg; 2016 May; 27(3):e305-9. PubMed ID: 27054429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypertonic saline nasal provocation stimulates nociceptive nerves, substance P release, and glandular mucous exocytosis in normal humans.
    Baraniuk JN; Ali M; Yuta A; Fang SY; Naranch K
    Am J Respir Crit Care Med; 1999 Aug; 160(2):655-62. PubMed ID: 10430743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contralateral effects of unilateral nasal decongestion.
    Bende M
    Acta Otolaryngol; 1985; 99(5-6):637-40. PubMed ID: 2411103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunoassay-based measurement of clinical biomarkers for monitoring changes in nasal cavity.
    Zhang YJ; Luroe S; Schieber F; Kelsey J; Nabbie F; Rizzi G; Richards P; Weiner R; Rhyne PW
    J Pharm Biomed Anal; 2009 Dec; 50(5):823-30. PubMed ID: 19625155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and tolerability of intranasally applied dimetindene maleate solution versus placebo in the treatment of seasonal allergic rhinitis.
    Horak F; Unkauf M; Beckers C; Mittermaier EM
    Arzneimittelforschung; 2000 Dec; 50(12):1099-105. PubMed ID: 11190775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Substance P theory: a unique focus on the painful and painless phenomena of cluster headache.
    Sicuteri F; Fanciullacci M; Nicolodi M; Geppetti P; Fusco BM; Marabini S; Alessandri M; Campagnolo V
    Headache; 1990 Jan; 30(2):69-79. PubMed ID: 1689282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An observational study of nasal cavity toxicity in cancer patients treated with bevacizumab.
    D'Amico M; Pagano M; Pasa A; Puntoni M; Clavarezza M; Gennari A; Gozza A; Zanardi S; Defferrari C; Provinciali N; Campazzi E; Campora S; Paleari L; Marra D; Petrera M; DeCensi A
    Expert Opin Drug Saf; 2014 Nov; 13(11):1437-42. PubMed ID: 25224760
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Painful conditioning stimuli of the craniofacial region evokes diffuse noxious inhibitory controls in men and women.
    Wang K; Svensson P; Sessle BJ; Cairns BE; Arendt-Nielsen L
    J Orofac Pain; 2010; 24(3):255-61. PubMed ID: 20664826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Capsaicin de-sensitization of the human nasal mucosa reduces pain and vascular effects of lactic acid and hypertonic saline.
    Rinder J; Stjärne P; Lundberg JM
    Rhinology; 1994 Dec; 32(4):173-8. PubMed ID: 7701224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nasal challenge with serotonin in asymptomatic hay fever patients.
    Tønnesen P; Schaffalitzky de Muckadell OB; Mygind N
    Allergy; 1987 Aug; 42(6):447-50. PubMed ID: 2444128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intranasal delivery of ciprofloxacin to rats: A topical approach using a thermoreversible in situ gel.
    Sousa J; Alves G; Oliveira P; Fortuna A; Falcão A
    Eur J Pharm Sci; 2017 Jan; 97():30-37. PubMed ID: 27810560
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of microdebrider-assisted inferior turbinoplasty and submucosal resection for children with hypertrophic inferior turbinates.
    Chen YL; Liu CM; Huang HM
    Int J Pediatr Otorhinolaryngol; 2007 Jun; 71(6):921-7. PubMed ID: 17418425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Substance P enhances antigen-evoked mediator release from human nasal mucosa.
    Baumgarten CR; Witzel A; Kleine-Tebbe J; Kunkel G
    Peptides; 1996; 17(1):25-30. PubMed ID: 8822506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nasal mucosal anaesthesia and airflow resistance.
    Cole P; Haight JS
    Rhinology; 1985 Sep; 23(3):209-12. PubMed ID: 4059805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of resection of the posterior nasal nerve on functional and morphological changes in the inferior turbinate mucosa.
    Ikeda K; Yokoi H; Saito T; Kawano K; Yao T; Furukawa M
    Acta Otolaryngol; 2008; 128(12):1337-41. PubMed ID: 18607960
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Techniques of intranasal drug use].
    Rapiejko P; Wojdas A; Ratajczak J; Szczygielski K; Jurkiewicz D
    Pol Merkur Lekarski; 2005 Sep; 19(111):400-2. PubMed ID: 16358885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline.
    Graf P; Juto JE
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(3):157-60. PubMed ID: 7515487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.